Insulin-like growth factor 2 axis supports the serum-independent growth of malignant rhabdoid tumor and is activated by microenvironment stress

Oncotarget
Ting LiXi Wang

Abstract

Malignant rhabdoid tumors (MRTs) are rare, lethal, pediatric tumors predominantly found in the kidney, brain and soft tissues. MRTs are driven by loss of tumor suppressor SNF5/INI1/SMARCB1/BAF47. The prognosis of MRT is poor using currently available treatments, so new treatment targets need to be identified to expand treatment options for patients experiencing chemotherapy resistance. The growth hormone insulin-like growth factor 2 (IGF2) signaling pathway is a promising target to overcome drug resistance in many cancers. Here, we evaluated the role of IGF2 axis in MRT cell proliferation. We showed that microenvironment stress, including starvation treatment and chemotherapy exposure, lead to elevated expression of IGF2 in the SNF5-deficient MRT cell line. The autocrine IGF2, in turn, activated insulin-like growth factor 1 receptor (IGF1R), insulin receptor (INSR), followed by PI3K/AKT pathway and RAS/ERK pathway to promote cancer cell proliferation and survival. We further demonstrated that impairment of IGF2 signaling by IGF2 neutralizing antibody, IGF1R inhibitor NVP-AEW541 or AKT inhibitor MK-2206 2HCl treatment prevented MRT cell growth in vitro. Taken together, our characterization of this axis defines a novel mechanism ...Continue Reading

References

Feb 1, 1995·Endocrine Reviews·J I Jones, D R Clemmons
Aug 9, 2003·Cancer Cell International·Silvano Nocentini
Jul 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joanne M HildenJaclyn A Biegel
Jan 11, 2005·The Journal of Pathology·E FoulstoneA B Hassan
Dec 1, 1995·Clinical Molecular Pathology·W ZumkellerP N Schofield
Aug 10, 2006·Journal of Cellular Physiology·Aubri CharboneauBernard Weissman
Apr 21, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J D'cunjaM A Grotzer
Jun 10, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Tanja NussbaumKai Breuhahn
Jul 22, 2008·Cancer Chemotherapy and Pharmacology·Kristen FosterCynthia Wright
Nov 26, 2008·Nature Reviews. Cancer·Michael Pollak
Jan 8, 2009·The Oncologist·Su Young KimLee J Helman
Apr 21, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gloria S HuangSusan Band Horwitz
May 12, 2010·Proceedings of the National Academy of Sciences of the United States of America·Danielle B UlanetDouglas Hanahan
Jun 29, 2010·Cancer Cell·Barry S TaylorWilliam L Gerald
Jan 5, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael Pollak
Jun 12, 2012·Endocrinology and Metabolism Clinics of North America·S John Weroha, Paul Haluska
Jun 23, 2012·Nature·Catherine S GrassoScott A Tomlins
Mar 27, 2013·Proceedings of the National Academy of Sciences of the United States of America·Julian C Lui, Jeffrey Baron
Oct 2, 2013·Endocrine-related Cancer·Callum Livingstone
Mar 7, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bin LiAnnie L M Cheung
Nov 18, 2014·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Zhennan TianJingshu Geng
Jan 8, 2015·Frontiers in Endocrinology·Joseph A M J L Janssen, Aimee J Varewijck
Feb 12, 2015·Cancer Cell·Samuel J VidalJosep Domingo-Domenech
Dec 15, 2015·Oncotarget·Laurensia YuniatiFrank N van Leeuwen
May 4, 2016·Proceedings of the National Academy of Sciences of the United States of America·Susana FragoAndrew Bassim Hassan
May 6, 2016·Frontiers in Oncology·Michael R Horsman, Peter Vaupel
May 8, 2016·Free Radical Biology & Medicine·Nicole SeebacherPatric J Jansson

❮ Previous
Next ❯

Citations

Mar 5, 2020·Neuro-oncology·Lindsey M HoffmanAnnie Huang
Mar 13, 2018·Expert Opinion on Therapeutic Targets·Karolina Nemes, Michael C Frühwald
Jun 22, 2021·Oncology Letters·Thomas CrezeeTheo S Plantinga

❮ Previous
Next ❯

Methods Mentioned

BETA
antisense oligonucleotides
PCR
electrophoresis
X-ray
Assay

Software Mentioned

GraphPad Prism

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.